The adapter between biotech operations and capital settlement
Growth-stage biotech firms and institutional investors operate on incompatible clocks. We built the infrastructure layer that reconciles both — inside Hong Kong's regulatory framework.
Hong Kong's framework is the architecture, not the obstacle
Most platforms treat compliance as overhead. We treat Hong Kong's SFC and HKMA requirements as the structural foundation — the moat that competitors cannot replicate without rebuilding from the layer up.
Settlement reconciliation gaps cost biotech operators 20+ hours per week. Our rails close that gap without requiring a change to existing lab or fund workflows.
Three operational layers, one integrated platform
Settlement Velocity
Biotech-Specific Workflows
Data as Collateral
Real-time reconciliation rails built for biotech capital events — clinical milestones, licensing tranches, equity closes — not generic corporate treasury flows.
Protocol-aware data pipelines that map lab-generated outputs to investor reporting formats without manual translation or compliance re-work at each handoff.
Healthcare data assets structured to meet institutional collateral standards — turning R&D output into a capital-efficiency lever rather than a compliance line item.
Built for your exact operational gap
Schedule a technical briefing. Bring your CTO, your CFO, and your current reconciliation workflow — we'll show you where the rails connect.